THE ULTIMATE OPTION FOR HORRIBLE PERIODS
Minerva is a quick, 1-time treatment that removes the lining of your uterus. Minerva is for women who do not wish to become pregnant in the future.
After receiving local anesthesia to numb the cervix, your doctor dilates the cervix and inserts a thin, soft wand through the vaginal opening and into your uterus.
The tip of the wand generates light and heat similar to a light bulb. In just 120 seconds the heat treats the lining of your uterus.
Most women are awake and alert during the treatment and describe the feeling as similar to menstrual cramps. Immediate side effects include temporary mild to moderate cramping and some discharge. These are typically managed with over-the-counter pain medicine.
The entire treatment takes less than 4 minutes. You will be ready to go home about 30 minutes after the treatment. You can rest for the remainder of the day and most women are back to a normal routine the following day.
“It’s no worse than a menstrual cramp. I’d rate it a 4 on a pain scale. It was easier than what I expected.”
—Andrea, S., Grand Rapids, MI
CHECK OUT THESE RESULTS!
of women
had their period totally eliminated with Minerva1
of women
had their period reduced to normal or less with Minerva1
of women
avoided having a hysterectomy with Minerva3
HOW WE COMPARE:
MINERVA
72% chance of zero bleeding
Available in your doctor’s office
No hormones
No foreign objects left in body
One-time treatment
Treats the cause of heavy bleeding
IUD & HORMONES4,5
20% chance of zero bleeding
Unwanted side effects for women 35+
Drug-based treatment
Foreign object remains in body
Potential for implant to migrate
Complaints of increased cramping & bleeding
HYSTERECTOMY
Major surgery
Loss of organ
Potential for disruption to endocrine system
Potential for early onset of menopausal symptoms
Complaints of mood swings & decreased libido
6-8 week recovery
Published outcomes of the two common
Endometrial Ablation treatments
1. Laberge P, Garza-Leal J, Fortin C, Grainger D, Johns DA, Adkins RT, Presthus J, Basinski C, Swarup M, Gimpelson R, Leyland N, Thiel J, Harris M, Burnett PE, Ray GF. A Randomized Controlled Multicenter US Food and Drug Administration Trial of the Safety and Efficacy of the Minerva Endometrial Ablation System: One-Year Follow-Up Results. J Minim Invasive Gynecol. 2017 Jan 1;24(1):124-132.
2. NovaSure Advanced Impedance Controlled Endometrial Ablation System. Instructions For Use and Controller Operator’s Manual. Available at: https://www.hologic.com/sites/default/files/2019-07/AW-09898-000_012_02(1)_RFC10 controller IFU_Rev 12.pdf. Accessed February 04, 2019. (Not based on a head-to-head study).
3. Minerva Surgical Endometrial Ablation System Operator’s Manual L0001 Rev. E. Available at: www.endmyperiod.com/manual. Accessed September 10, 2019.
4. Department of Health and Human Services. The Food and Drug Administration. Center for Drug Evaluation and Research. Labeling for Combined Hormonal Contraceptives.Guidance for Industry. Available at: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM590673.pdf. Accessed February 04, 2019.
5. Department of Health and Human Services. The Food and Drug Administration. Center for Drug Evaluation and Research. Application Number: NDA 021225 S-031. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/021225orig1s031.pdf. Accessed February 04, 2019.